Literature DB >> 32433433

Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.

Henkjan J Verkade1, Richard J Thompson2, Henrik Arnell3, Björn Fischler3, Per-Göran Gillberg4, Jan P Mattsson4, Kristina Torfgård4, Erik Lindström4.   

Abstract

OBJECTIVES: We assessed available data on impact of partial external biliary diversion (PEBD) surgery on clinical outcomes in patients with progressive familial intrahepatic cholestasis (PFIC).
METHODS: We performed a systematic literature review (PubMed) and meta-analysis to evaluate relationships between liver biochemistry parameters (serum bile acids, bilirubin, and alanine aminotransferase [ALT]) and early response (pruritus improvement) or long-term outcomes (need for liver transplant) in patients with PFIC who underwent PEBD.
RESULTS: Searches identified 175 publications before September 2018; 16 met inclusion criteria. Receiver operating characteristic (ROC) analysis examined ability of liver biochemistry parameters to discriminate patients who demonstrated early and long-term response to PEBD from those who did not. Regarding pruritus improvement in 155 included patients in aggregate, 104 (67%) were responders, 14 (9%) had partial response, and 37 (24%) were nonresponders. In ROC analyses of individual patient data, post-PEBD serum concentration of bile acids, in particular, could discriminate responders from nonresponders for pruritus improvement (area under the curve, 0.99; P < 0.0001; n = 42); to a lesser extent, this was also true for bilirubin (0.87; P = 0.003; n = 31), whereas ALT could not discriminate responders from nonresponders for pruritus improvement (0.74; P = 0.06; n = 28). Reductions from pre-PEBD values in serum bile acid concentration (0.89; P = 0.0003; n = 32) and bilirubin (0.98; P = 0.002; n = 18) but not ALT (0.62; P = 0.46; n = 18) significantly discriminated decreased aggregate need for liver transplant.
CONCLUSION: Changes in bile acids seem particularly useful in discriminating early and long-term post-PEBD outcomes and may be potential biomarkers of response to interruption of enterohepatic circulation in patients with PFIC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32433433     DOI: 10.1097/MPG.0000000000002789

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis.

Authors:  Christoph Slavetinsky; Ekkehard Sturm
Journal:  BMJ Case Rep       Date:  2020-06-29

Review 2.  Cholestasis-Associated Pruritus and Its Pruritogens.

Authors:  Jacqueline A G M Langedijk; Ulrich H Beuers; Ronald P J Oude Elferink
Journal:  Front Med (Lausanne)       Date:  2021-03-09

Review 3.  Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review.

Authors:  Tracey Jones-Hughes; Jo Campbell; Louise Crathorne
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

Review 4.  Newer variants of progressive familial intrahepatic cholestasis.

Authors:  Vignesh Vinayagamoorthy; Anshu Srivastava; Moinak Sen Sarma
Journal:  World J Hepatol       Date:  2021-12-27

Review 5.  Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies.

Authors:  Seema Alam; Bikrant Bihari Lal
Journal:  World J Hepatol       Date:  2022-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.